We are live on !
Find out more
Bartlett & Co Portfolio holdings
AUM
$6.16B
Turnover
12.86%
1-Year Est. Return
20.29%
This Fund
S&P 500
This Quarter Est. Return
+10.4%
1 Year Est. Return
+20.29%
3 Year Est. Return
+30.84%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$6.16B
AUM Growth
+$590M
(+11%)
Cap. Flow
+$26M
Cap. Flow % of AUM
Cap. Flow %
0.42%
Top 10 Holdings %
Top 10 Hldgs %
30.5%
Holding
1,314
New
118
Increased
226
Reduced
290
Closed
51
Avg Time Held
3.3
years
Top 10 Avg Time Held
4.2
years
Top 20 Avg Time Held
5.7
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Chevron
CVX
|
+$26.9M |
| 2 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$11.7M |
| 3 |
Procter & Gamble
PG
|
+$11M |
| 4 |
McCormick & Company Non-Voting
MKC
|
+$10M |
| 5 |
JPMorgan US Quality Factor ETF
JQUA
|
+$9.04M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Enbridge
ENB
|
+$47.6M |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$12.7M |
| 3 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$7.97M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$5.21M |
| 5 |
NextEra Energy
NEE
|
+$4.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.28% |
| 2 | Miscellaneous | 17.67% |
| 3 | Healthcare | 12.33% |
| 4 | Financials | 11.49% |
| 5 | Industrials | 9.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
201
L3Harris
LHX
$45.4B
| $2.04M | 0.03% |
9,683
+119
| +1% | +$22.3K |
2019 Q3
17 quarters
|
|
202
Vanguard International High Dividend Yield ETF
VYMI
$21.4B
| $2.02M | 0.03% |
30,478
| – | – |
2017 Q4
24 quarters
|
|
203
Micron Technology
MU
$1.02T
| $2.02M | 0.03% |
23,525
-2,129
| -8% | -$158K |
2015 Q2
34 quarters
|
|
204
Vanguard Morningstar Large-Cap ETF
VV
$54.4B
| $2.01M | 0.03% |
9,178
+62
| +0.7% | +$12.7K |
2013 Q2
42 quarters
|
|
205
Northern Trust
NTRS
$30.1B
| $1.97M | 0.03% |
23,030
-620
| -3% | -$45.8K |
2019 Q3
17 quarters
|
|
206
Carrier Global
CARR
$45.5B
| $1.91M | 0.03% |
32,968
-1,337
| -4% | -$70.7K |
2020 Q2
14 quarters
|
|
207
General Mills
GIS
$17.4B
| $1.89M | 0.03% |
29,154
-601
| -2% | -$38.8K |
2013 Q2
42 quarters
|
|
208
AT&T
T
$159B
| $1.86M | 0.03% |
111,073
-14,732
| -12% | -$233K |
2013 Q2
42 quarters
|
|
209
Vanguard Morningstar Growth ETF
VUG
$230B
| $1.81M | 0.03% |
34,866
-222
| -0.6% | -$10.7K |
2013 Q2
42 quarters
|
|
210
Air Products & Chemicals
APD
$66.5B
| $1.79M | 0.03% |
6,523
-1,310
| -17% | -$360K |
2013 Q2
42 quarters
|
|
211
Goldman Sachs
GS
$255B
| $1.78M | 0.03% |
4,612
+1,270
| +38% | +$424K |
2013 Q2
42 quarters
|
|
212
Advanced Micro Devices
AMD
$878B
| $1.72M | 0.03% |
11,545
+25
| +0.2% | +$2.95K |
2022 Q1
7 quarters
|
|
213
GE Aerospace
GE
$323B
| $1.71M | 0.03% |
16,659
+7,175
| +76% | +$665K |
2013 Q2
42 quarters
|
|
214
Invesco QQQ Trust
QQQ
$485B
| $1.67M | 0.03% |
4,067
+158
| +4% | +$60K |
2013 Q2
42 quarters
|
|
215
Elevance Health
ELV
$93.3B
| $1.67M | 0.03% |
3,565
+99
| +3% | +$45.8K |
2013 Q2
42 quarters
|
|
216
Vanguard Real Estate ETF
VNQ
$36.4B
| $1.67M | 0.03% |
18,634
-17
| -0.1% | -$1.35K |
2013 Q2
42 quarters
|
|
217
PNC Financial Services
PNC
$86.3B
| $1.64M | 0.03% |
10,553
-2,155
| -17% | -$279K |
2013 Q2
42 quarters
|
|
218
Marriott International
MAR
$102B
| $1.63M | 0.03% |
7,281
+3,005
| +70% | +$609K |
2013 Q2
42 quarters
|
|
219
Fifth Third Bancorp
FITB
$45.8B
| $1.63M | 0.03% |
46,343
+1,844
| +4% | +$51.1K |
2013 Q2
42 quarters
|
|
220
Yum China
YUMC
$15.2B
| $1.63M | 0.03% |
38,515
-300
| -0.8% | -$14K |
2016 Q4
28 quarters
|
|
221
Vanguard ESG US Stock ETF
ESGV
$13.4B
| $1.61M | 0.03% |
18,880
+2,200
| +13% | +$173K |
2021 Q3
9 quarters
|
|
222
Verizon
VZ
$183B
| $1.6M | 0.03% |
42,564
-29,040
| -41% | -$1.03M |
2013 Q2
42 quarters
|
|
223
Marsh
MRSH
$90B
| $1.59M | 0.03% |
8,411
| – | – |
2013 Q2
42 quarters
|
|
224
ON Semiconductor
ON
$28.5B
| $1.58M | 0.03% |
18,550
-130
| -0.7% | -$10.2K |
2023 Q2
2 quarters
|
|
225
Prudential Financial
PRU
$39.2B
| $1.57M | 0.03% |
15,029
+150
| +1% | +$14.4K |
2022 Q1
7 quarters
|
|
Similar funds
Bartlett & Co's Q4 2023 Portfolio in Review
As of Q4 2023, Bartlett & Co held 1,314 positions worth $6.16B, up 11% from $5.57B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Bartlett & Co's Q4 2023 filing shows 118 new, 226 increased, 290 reduced and 51 closed positions. Its largest new stake was JPMorgan US Quality Factor ETF: 201,376 shares worth $9.7M. The largest sale was Enbridge, an estimated $47.6M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Miscellaneous and Healthcare.
- Bartlett & Co's largest Q4 2023 buy was JPMorgan US Quality Factor ETF: 201,376 shares worth $9.7M.
- Bartlett & Co added most to Chevron in Q4 2023, an estimated $26.9M increase.
- Bartlett & Co's biggest Q4 2023 reduction was Enbridge, cutting an estimated $47.6M.
- Bartlett & Co fully exited Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2023, selling an estimated $7.97M.
- Bartlett & Co's ten largest holdings make up 30% of its $6.16B portfolio in Q4 2023.
- Bartlett & Co opened 118 new positions and closed 51 in Q4 2023.
- Bartlett & Co's portfolio value rose 11% quarter-over-quarter to $6.16B.
Based on Bartlett & Co's 13F filing for Q4 2023, filed 8 Jan 2024.